Susan E. Funk, MBA, FACHE
Advertisement
Articles by Susan E. Funk, MBA, FACHE
Advertisement
Latest Updated Articles
- Evaluation of Clinical Outcomes and Costs Based on Prescribed Dose Level of Renin-Angiotensin-Aldosterone System Inhibitors
Published: August 31st 2016 | Updated:
- All-Cause Costs Increase Exponentially with Increased Chronic Kidney Disease Stage
Published: June 21st 2017 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
3
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
4
Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial
5
